Literature DB >> 12926

Fosfomycin: Absorption and excretion.

K Shimizu.   

Abstract

Summarized results of absorption and excretion of fosfomycin after oral and intravenous administration obtained from hospitals and institutions in Japan are reported. Fosfomycin was rapidly absorbed and excreted from the urine once it was distributed, the 6-hour urinary recovery reaching about 20% in the case of oral administration and 90% in the case of intravenous injection. These phenomena are almost the same as those previously published. Higher concentration was noticed in the kidney, which gradually decreased according to the fall of the blood level. The blood level reached its maximum of about 3 mug/ml after oral administration to adults at a dose of 500 mg.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 12926     DOI: 10.1159/000222042

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  6 in total

1.  Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity.

Authors:  T Bergan
Journal:  Infection       Date:  1990       Impact factor: 3.553

2.  Fosfomycin trometamol: historical background and clinical development.

Authors:  G Gialdroni Grassi
Journal:  Infection       Date:  1990       Impact factor: 3.553

3.  Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults.

Authors:  F Borsa; A Leroy; J P Fillastre; M Godin; B Moulin
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

4.  IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis.

Authors:  Zoe Kane; Silke Gastine; Christina Obiero; Phoebe Williams; Sheila Murunga; Johnstone Thitiri; Sally Ellis; Erika Correia; Borna Nyaoke; Karin Kipper; John van den Anker; Mike Sharland; James A Berkley; Joseph F Standing
Journal:  J Antimicrob Chemother       Date:  2021-06-18       Impact factor: 5.790

Review 5.  Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Authors:  Anneke Corinne Dijkmans; Natalia Veneranda Ortiz Zacarías; Jacobus Burggraaf; Johan Willem Mouton; Erik Bert Wilms; Cees van Nieuwkoop; Daniel Johannes Touw; Jasper Stevens; Ingrid Maria Catharina Kamerling
Journal:  Antibiotics (Basel)       Date:  2017-10-31

6.  Induction of Melanogenesis by Fosfomycin in B16F10 Cells Through the Upregulation of P-JNK and P-p38 Signaling Pathways.

Authors:  Sana Ullah; You Chul Chung; Chang-Gu Hyun
Journal:  Antibiotics (Basel)       Date:  2020-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.